Sheila Riazi, MD Presents on MH at ORNAC Conference
MHAUS is happy to announce that Sheila Riazi, MSc, MD, FRCPC; of Toronto General Hospital Director of the Malignant Hyperthermia Investigation Unit and member of the Board of Directors and Professional Advisory Council of Malignant Hyperthermia Association of the United States (MHAUS) will be presenting a session on Malignant Hyperthermia at the Operating Room Nurses Association of Canada (ORNAC) National Conference titled "Bridging Excellence in Perioperative Practice" held May 3-7 2015 at the Shaw Convention Center in Edmonton, Alberta, Canada. Click here to read more about the conference.
About Sheila Riazi, MD
Dr. Riazi is an accomplished academic anesthesiologist who has focused her research efforts on Malignant Hyperthermia. In 2010 she assumed the leadership of the MH diagnostic unit at the University of Toronto where she oversees muscle biopsy testing as well as a varied research program. She is assisted in those endeavors by Dr. Natasha Kraeva and Wanda Frodis, who were first recruited to the testing center by the legendary Beverly Britt.
Dr. Riazi has published several important papers related to the molecular genetics and muscle pathology of MH patients and was a contributor to the review article on the NIH web site that summarizes the latest information on inherited disorders, GeneTests.
Most recently Dr. Riazi was the host and one of the organizers of the recent MHAUS Scientific Conference held at the University of Toronto. She and her colleagues are now summarizing the proceedings of that conference for publication.
In addition to these roles, Dr. Riazi teaches medical students and residents in anesthesia and has developed a unique elective experience for Anesthesia residents desirous to learn more about MH.”
“Dr. Riazi, as an outstanding clinician, educator and researcher and will be a valuable member of the MHAUS Professional Advisory Council, says MHAUS PAC Chair, Robert T. Dirksen, PhD.
Dr. Riazi has been extremely productive in terms of both clinical and basic research investigations of MH and other RyR1-related disorders and has been published in several high-impact, peer-reviewed journals and has secured grant funding for her research from a number of sources. Dr. Riazi has also developed new and innovative educational programs related to MH. In addition to her contributions to MH research and education, Dr. Riazi has demonstrated strong leadership skills as evidenced by her successfully revitalizing the MH Investigation Unit at the University of Toronto, being appointed to the North American MH Registry Advisory Council, and playing a key role in the scientific and administrative organization of the 2013 MHAUS Scientific Conference in Toronto. Click here to read more about Dr. Riazi.